Shared decision‐making for patients with vaccine‐related concerns of blood transfusion: A single institution experience
- 24 October 2024
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 64 (12) , 2247-2251
Abstract
Background: Some patients express concerns regarding receipt of allogeneic blood transfusions from donors potentially vaccinated against SARS‐CoV‐2 (COVID‐19). However, limited information exists about patients' expression of these concerns or how to address them during the blood transfusion consent process. In this study, we describe our experience of working collaboratively with patients with vaccine‐related transfusion concerns prior to elective surgery, summarizing treatment decisions and clinical outcomes.Study Design and Methods: This observational descriptive study includes patients seen in our Bloodless Medicine and Surgery clinic between June 2022 and June 2024 for vaccine‐related transfusion concerns prior to elective surgery. A shared decision‐making framework was employed to foster conversation, share information, provide reassurance, reconcile conflict, and match preferences with available care options. Patient characteristics, treatment decisions, and surgical outcomes were reviewed and summarized.Results: Thirty‐five patients were included, with median (1st, 3rd quartile) age of 61 (53, 69) years. Cardiac surgery was the most common type of surgery (29%). Twelve patients (34%) were anemic preoperatively, and all received preoperative treatment. After discussion with a Bloodless Medicine specialist, 24 (68.6%) decided to consent to the use of all blood products, 5 (14.3%) accepted only red blood cells, and 6 (17.1%) declined all blood products. Among 28 patients undergoing surgery, only 4 (14%) received allogeneic transfusion perioperatively.Conclusion: Many patients concerned about the vaccination status of blood donors may ultimately consent to allogeneic blood products after shared decision‐making with a Bloodless Medicine specialist, highlighting the importance of patient empowerment and collaborative care.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (K23HL153310)
This publication has 5 references indexed in Scilit:
- Addressing Patient Concerns with Blood Transfusion from Donors Vaccinated Against COVID-19: A Clinician PrimerAnesthesiology, 2024
- Clinical outcomes in hospitalized plasma and platelet transfusion recipients prior to and following widespread blood donor SARS‐CoV‐2 infection and vaccinationTransfusion, 2023
- Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status — United States, April 2021–September 2022MMWR. Morbidity and Mortality Weekly Report, 2023
- Shared decision-making as a method of careBMJ Evidence-Based Medicine, 2022
- Refusing blood transfusions from COVID‐19‐vaccinated donors: are we repeating history?British Journal of Haematology, 2021